Tuesday, December 5, 2023
Clinical Advances in
Read Overview
Supported by an independent educational grant from
Otsuka America Pharmaceutical Inc. and Lundbeck
Steering Committee Member Chair
William B. and Sheila Konar Professor of Psychiatry, Neurology, Neuroscience, and Medicine
University of Rochester School of Medicine and Dentistry
Rochester, New York
Professor and Director
Division of Geriatric Psychiatry
Department of Psychiatry and Behavioral Sciences
St Louis School of Medicine
St Louis, Missouri
Professor of Psychiatry, Neurology, Epidemiology, and Pathology
Hotchkiss Brain Institute and O’Brien Institute of Public Health
University of Calgary
Calgary, Canada
John Romano Professor and Chair of Psychiatry
University of Rochester Medical Center
Rochester, New York
Friends of Alzheimer’s Research Professor of Psychiatry
University of Washington School of Medicine
Seattle, Washington
Professor of Psychiatry and Behavioral Sciences
Johns Hopkins School of Medicine
Baltimore, Maryland
Has the following relevant financial relationships:
Consultant or advisor for: Acadia Pharmaceuticals; Athira; Biogen; Cognitive Research Corp; Eisai; Functional Neuromodulation; IQVIA; Lundbeck; Maplight Therapeutics; Merck; MJH Life Sciences; Novartis
Research funding from: Alector; Athira; Biogen; Biohaven; Cassava; Eisai; Eli Lilly; Genentech/Roche; Vaccinex
Other: Scientific Advisory Board for Alzheon (not compensated)
Has the following relevant financial relationships:
Consultant or advisor for: Acadia; Avanir; Axsome; Biogen; BioXcel; Genentech; Karuna; Lundbeck; Otsuka; Roche; Takeda
Speaker or member of speakers bureau for: Acadia (ended January 2022); Biogen (ended January 2022)
Research funding from: Janssen; Lilly
Other: Safety Monitoring Committees: Anavex; EryDel; Intra-cellular Therapies; Merck; Newron
Has the following relevant financial relationships:
Consultant or advisor for: Biogen; Lundbeck/Otsuka; Roche
Has no relevant financial relationships.
Has the following relevant financial relationships:
Consultant or advisor for: Avanir; Acadia; Eli Lilly; Alpha Cognition; Genentech
Research funding from: Eli Lilly; Eisai
Owns stock (publicly traded) in: Bristol Meyers Squibb
Has the following relevant financial relationships:
Consultant or advisor for: GLG; Leerink; Cerevel; Cerevance; BioXcel; Sunovion; Acadia; Medalink; Novo Nordisk; Noble Insights; TwoLabs; Otsuka; Lundbeck; MedaCorp; Expert Connect; HMP Global
Research funding from: Functional Neuromodulation; Lilly
Other: Data Safety Monitoring Board: Synaptogenix
